Implementation of echocardiographic contrast agents into clinical practice: A United Kingdom National Health Service Survey on behalf of the British Society of Echocardiography

European Heart Journal Cardiovascular Imaging

Volumn 14, Issue 6, 2013, Pages 550-554

  Bhattacharyya, Sanjeev ^a   Khattar, Rajdeep ^a   Lloyd, Guy ^b   Senior, Roxy ^a,c  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b British Society of Echocardiography   (United Kingdom)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Contrast; Echocardiography

Indexed keywords

CONTRAST MEDIUM; PERFLUTREN; SONOVUE;

ARTICLE; CARDIAC IMAGING; CARDIOLOGIST; CLINICAL PRACTICE; CLINICAL PROTOCOL; CONTRAST ECHOCARDIOGRAPHY; CONTRAST ENHANCEMENT; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; HEALTH CARE PLANNING; HEALTH CARE SURVEY; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMAGE QUALITY; NATIONAL HEALTH SERVICE; PATIENT MONITORING; PATIENT REFERRAL; PRIORITY JOURNAL; QUESTIONNAIRE; REIMBURSEMENT; STAFF TRAINING; STRESS ECHOCARDIOGRAPHY; UNITED KINGDOM; VASCULAR ACCESS; WORKFLOW;

CONTRAST; ECHOCARDIOGRAPHY;

CARDIOLOGY SERVICE, HOSPITAL; CONTRAST MEDIA; COST-BENEFIT ANALYSIS; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, STRESS; FEMALE; GREAT BRITAIN; HEALTH CARE SURVEYS; HUMANS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; QUESTIONNAIRES; SOCIETIES, MEDICAL; STATE MEDICINE;

EID: 84877993046     PISSN: 20472404     EISSN: None     Source Type: Journal    
DOI: 10.1093/ehjci/jes212     Document Type: Article

References (16)

1. Kurt M, Shaikh KA, Peterson L, Kurrelmeyer KM, Shah G, Nagueh SF et al. Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort. J Am Coll Cardiol 2009;53:802-10.
2. Reilly JP, Tunick PA, Timmermans RJ, Stein B, Rosenzweig BP, Kronzon I. Contrast echocardiography clarifies uninterpretable wall motion in intensive care unit patients. J Am Coll Cardiol 2000;35:485-90. (Pubitemid 30125542)
3. Bernier M, Abdelmoneim SS, Moir S, McCully RB, Pellikka PA, Mulvagh SL. Pretest score for predicting microbubble contrast agent use in stress echocardiography: a method to increase efficiency in the echo laboratory. Cardiol Res Pract 2009;2009: 308-486.
4. Olszewski R, Timperley J, Cezary S, Monaghan M, Nihoyannopoulos P, Senior R et al. The clinical applications of contrast echocardiography. Eur J Echocardiogr 2007;8:513-23.
5. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012;33: 1787-847.
6. Jones AL, Barlow M, Barrett-Lee PJ, Canney PA, Gilmour IM, Robb SD et al. Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring. Br J Cancer 2009;100:684-92.
7. Hundley WG, Kizilbash AM, Afridi I, Franco F, Peshock RM, Grayburn PA. Administration of an intravenous perflurocarbon contrast agent improves echocardio-graphic determination of left ventricular volumes and ejection fraction: comparison with cine magnetic resonance imaging. J Am Coll Cardiol 1998;32: 1426-32.
8. Malm S, Frigstad S, Sagberg E, Larsson H, Skjaerpe T. Accurate and reproducible measurement of left ventricular volume and ejection fraction by contrast echo-cardiography: a comparison with magnetic resonance imaging. J Am Coll Cardiol 2004;44:1030-1035. (Pubitemid 39165138)
9. Senior R, Becher H, Monaghan M, Agati L, Zamorano J, Vanoverschelde JL et al. Contrast echocardiography: evidence-based recommendations by European Association of Echocardiography. Eur J Echocardiogr 2009;10:194-212.
10. Mulvagh SL, Rakowski H, Vannan MA, Abdelmoneim SS, Becher H, Bierig M et al. American Society of Echocardiography consensus statement on the clinical applications of ultrasonic contrast agents in echocardiography. J Am Soc Echocardiogr 2008;21:1179-201.
11. Thanigaraj S, Nease RF Jr, Schechtman KB, Wade RL, Loslo S, Pérez JE. Use of contrast for image enhancement during stress echocardiography is cost-effective and reduces additional diagnostic testing. Am J Cardiol 2001;87:1430-32. (Pubitemid 32523039)
12. Shaw LJ, Monaghan MJ, Nihoyannopolous P. Clinical and economic outcomes assessment with myocardial contrast echocardiography. Heart 1999; (Suppl 3)82: III16-21. (Pubitemid 29515439)
13. Wei K, Mulvagh SL, Carson L, Davidoff R, Gabriel R, Grimm RA et al. The safety of definity and optison for ultrasound image enhancement: a retrospective analysis of 78, 383 administered contrast doses. J Am Soc Echocardiogr 2008;21: 1202-2106.
14. Herzog CA. Incidence of adverse events associated with use of perflutren contrast agents for echocardiography. JAMA 2008;299:2023-25. (Pubitemid 351656599)
15. Kusnetzky LL, Khalid A, Khumri TM, Moe TG, Jones PG, Main ML. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent. J Am Coll Cardiol 2008;51:1704-6.
16. ICAEL Standards For Accreditation In Adult Echocardiography Testing. Parts I through IV. Available at. http://www.intersocietal.org/echo/standards/ IAC-Adult-Echocardiography-Standards.pdf (28 June 2012, date last accessed).